Zweig Di Menna Associates LLC Novo Nordisk A S Transaction History

Zweig Di Menna Associates LLC

  • $951 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
BUY
$122.71 - $146.91 $1.12 Million - $1.34 Million
9,100 Added 17.5%
61,100 $8.72 Million
Q1 2024

Apr 29, 2024
BUY
$102.11 - $135.92 $5.31 Million - $7.07 Million
52,000 New
52,000 $6.68 Million
Q4 2022

Feb 07, 2023
BUY
$102.55 - $135.33 $9.13 Million - $12 Million
89,000 New
89,000 $12 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $188B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email